Edwards Lifesciences Corporation
IT ˙ BIT ˙ US28176E1082
74,12 € 0,00 (0,00%)
2026-06-04
PREZZO DELLE AZIONI
SecurityIT:1EW / Edwards Lifesciences Corporation
InstitutionEquitable Trust Co
Latest Disclosed Ownership69,444 shares
Latest Disclosed Value $ 5,561,076
Equitable Trust Co reports 7.59% increase in ownership of 1EW / Edwards Lifesciences Corporation

On April 30, 2026 - Equitable Trust Co filed a 13F-HR form disclosing ownership of 69,444 shares of Edwards Lifesciences Corporation (IT:1EW) valued at $4,697,887 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 64,548 shares of Edwards Lifesciences Corporation. This represents a change in shares of 7.59% during the quarter. The current value of the position is $5,147,189 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F Edwards Lifesciences Com 28176E108 69,444 4,896 7.59 5,561 1.07 0.1513
2026-02-02 2025-12-31 13F Edwards Lifesciences Com 28176E108 64,548 11,035 20.62 5,503 32.23 0.1455
2025-11-10 2025-09-30 13F Edwards Lifesciences Com 28176E108 53,513 -15,075 -21.98 4,162 -22.43 0.1913
2025-07-23 2025-06-30 13F Edwards Lifesciences Com 28176E108 68,588 -6,685 -8.88 5,364 -1.67 0.2673
2025-04-25 2025-03-31 13F Edwards Lifesciences Com 28176E108 75,273 2,231 3.05 5,456 0.89 0.3022
2025-01-28 2024-12-31 13F Edwards Lifesciences Com 28176E108 73,042 7,154 10.86 5,407 24.38 0.3018
2024-10-29 2024-09-30 13F Edwards Lifesciences Com 28176E108 65,888 52,154 379.74 4,348 242.82 0.2790
2024-07-31 2024-06-30 13F Edwards Lifesciences Com 28176E108 13,734 2,115 18.20 1,269 14.23 0.0873
2024-04-24 2024-03-31 13F Edwards Lifesciences Com 28176E108 11,619 962 9.03 1,110 36.70 0.0770
2024-01-25 2023-12-31 13F Edwards Lifesciences Com 28176E108 10,657 5,129 92.78 813 112.57 0.0611
2023-11-06 2023-09-30 13F Edwards Lifesciences Com 28176E108 5,528 521 10.41 383 -19.07 0.0317
2023-08-08 2023-06-30 13F Edwards Lifesciences Com 28176E108 5,007 197 4.10 472 18.89 0.0361
2023-05-02 2023-03-31 13F Edwards Lifesciences Com 28176E108 4,810 0 0.00 398 10.89 0.0313
2023-02-17 2022-12-31 13F Edwards Lifesciences Com 28176E108 4,810 1,308 37.35 359 23.88 0.0283
2022-10-31 2022-09-30 13F Edwards Lifesciences Com 28176E108 3,502 0 0.00 289 -13.21 0.0241
2022-07-15 2022-06-30 13F Edwards Lifesciences Com 28176E108 3,502 202 6.12 333 -14.18 0.0248
2022-05-06 2022-03-31 13F Edwards Lifesciences Com 28176E108 3,300 0 0.00 388 -9.35 0.0249
2022-01-31 2021-12-31 13F Edwards Lifesciences Com 28176E108 3,300 3,300 428 0.0264
2021-10-26 2021-09-30 13F Edwards Lifesciences Com 28176E108 0 -5,313 -100.00 0 -100.00
2021-08-03 2021-06-30 13F Edwards Lifesciences Com 28176E108 5,313 -4,883 -47.89 550 -35.52 0.0353
2021-05-14 2021-03-31 13F Edwards Lifesciences Com 28176E108 10,196 0 0.00 853 -8.28 0.0635
2021-02-12 2020-12-31 13F Edwards Lifesciences Com 28176E108 10,196 413 4.22 930 19.08 0.0690
2020-11-13 2020-09-30 13F Edwards Lifesciences Com 28176E108 9,783 -366 -3.61 781 11.25 0.0665
2020-08-18 2020-06-30 13F Edwards Lifesciences Com 28176E108 10,149 6,108 151.15 702 -7.87 0.0646
2020-05-21 2020-03-31 13F Edwards Lifesciences Com 28176E108 4,041 2,821 231.23 762 167.37 0.0837
2020-02-18 2019-12-31 13F Edwards Lifesciences Com 28176E108 1,220 0 0.00 285 6.34 0.0278
2019-11-19 2019-09-30 13F Edwards Lifesciences Com 28176E108 1,220 0 0.00 268 19.11 0.0282
2019-08-16 2019-06-30 13F Edwards Lifesciences Com 28176E108 1,220 -71 -5.50 225 -8.91 0.0239
2019-05-15 2019-03-31 13F Edwards Lifesciences Com 28176E108 1,291 1,291 247 0.0285
2019-02-22 2018-12-31 13F Edwards Lifesciences Com 28176E108 0 -1,220 -100.00 0 -100.00
2018-11-15 2018-09-30 13F Edwards Lifesciences Com 28176E108 1,220 1,220 212 0.0247
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.